FutureMIND · Training Europe’s Future Leaders in AI-driven Neuro-Oncology Diagnostics and Discovery
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2027-01-01 → 2030-12-31
- Финансиране от ЕС
- 4 379 817 €
- Участници
- 17
- Схема
- HORIZON-TMA-MSCA-DN
Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.
Накратко на български
Изкуственият интелект се прилага в невроонкологията за по-точна диагностика и класификация на тумори в мозъка, като например глиобластомите. Това помага за преодоляване на разликата между техническите разработки и реалната клинична практика, за да се подобри грижата за пациентите.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
Neuro-oncology, at the crossroads of neuroscience and cancer care, plays a crucial role in treating some of the most aggressive and complex malignancies, such as glioblastomas. Despite recent advancements in research and technoloNeuro-oncology, at the crossroads of neuroscience and cancer care, plays a crucial role in treating some of the most aggressive and complex malignancies, such as glioblastomas. Despite recent advancements in research and technology, the field continues to face major hurdles in early detection, risk-adapted surgery, accurate tumour classification, and the development of effective personalized treatments, underscoring the urgent need for innovative solutions to improve patient outcomes. Current advancements in computer science, particularly in artificial intelligence (AI), are revolutionizing medicine and offer unprecedented opportunities to improve areas that have historically seen limited progress, such as neuro-oncological care. However, critical gaps remain between technical innovations and their clinical application. Moreover, physicians often lack the technical background to fully utilize AI, while computer science developments may not always address clinical realities. The FutureMIND Doctoral Network aims to bridge these divides and fill in the gap of holistic experts needed to advance AI-driven diagnostics and discovery in neuro-oncology. FutureMIND brings together leading researchers, clinicians and entrepreneurs from eight countries to train 14 Doctoral Candidates (DCs) across different disciplines and sectors. By the end of FutureMIND, the DCs will be equipped to advance digital medicine as a new clinical tool to tackle brain cancers, with foreseeable impact on thousands of patients. Importantly, FutureMIND will prepare a new generation of European experts capable of addressing future challenges and of preparing the EU to sovereignly lead the digital transformation in neuro-oncology, paradigmatically for other areas of medical care.
Оригинален текст от CORDIS (на английски).
Участници
- RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG · HeidelbergКоординаторГермания
- BRAINLAB SE · MUNCHENГермания
- CERCARE MEDICAL APS · Aarhus CДания
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG · HeidelbergГермания
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM · RotterdamНидерландия
- FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG · ErlangenГермания
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III · MadridИспания
- Heidelberg Epignostix GmbH · HeidelbergНиво градГермания
- INVENIO IMAGING INC · Santa ClaraНиво градСъединени щати
- Johner Institut GmbH · KonstanzГермания
- KAROLINSKA INSTITUTET · STOCKHOLMШвеция
- OXFORD NANOPORE TECHNOLOGIES LTD · OxfordОбединеното кралство
- PROTEOTYPE DIAGNOSTICS LTD · CambridgeОбединеното кралство
- THE QUEEN'S UNIVERSITY OF BELFAST · BELFASTОбединеното кралство
- THE UNIVERSITY OF NOTTINGHAM · NottinghamОбединеното кралство
- UNIVERSIDAD AUTONOMA DE MADRID · MadridИспания
- UNIVERSITETET I OSLO · OsloНорвегия
Връзки
Данни: CORDIS, © Европейски съюз